Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht; Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht.
Br J Gen Pract. 2020 Nov 26;70(701):e858-e865. doi: 10.3399/bjgp20X713693. Print 2020 Dec.
It is recognised that medical tests are overused in primary care; however, it is unclear how best to reduce their use.
To identify which strategies are effective in reducing the use of low-value medical tests in primary care settings.
Systematic review.
The databases MEDLINE, EMBASE, and Rx for Change were searched (January 1990 to November 2019) for randomised controlled trials (RCTs) that evaluated strategies to reduce the use of low-value medical tests in primary care settings. Two reviewers selected eligible RCTs, extracted data, and assessed their risk of bias.
Of the 16 RCTs included in the review, 11 reported a statistically significant reduction in the use of low-value medical tests. The median of the differences between the relative reductions in the intervention and control arms was 17% (interquartile range 12% to 24%). Strategies using reminders or audit/feedback showed larger reduction than those without these components (22% versus 14%, and 22% versus 13%, respectively) and patient-targeted strategies showed larger reductions than those not targeted at patients (51% versus 17%). Very few studies investigated the sustainability of the effect, adverse events, cost-effectiveness, or patient-reported outcomes related to reducing the use of low-value tests.
This review indicates that it is possible to reduce the use of low-value medical tests in primary care, especially by using multiple components including reminders, audit/feedback, and patient-targeted interventions. To implement these strategies widely in primary care settings, more research is needed not only to investigate their effectiveness, but also to examine adverse events, cost-effectiveness, and patient-reported outcomes.
人们认识到,在初级保健中过度使用了医学检测;然而,尚不清楚如何才能最好地减少其使用。
确定哪些策略可有效减少初级保健环境中低价值医学检测的使用。
系统评价。
检索 MEDLINE、EMBASE 和 Rx for Change 数据库(1990 年 1 月至 2019 年 11 月),以评估在初级保健环境中减少低价值医学检测使用的策略的随机对照试验(RCT)。两位评审员选择合格的 RCT,提取数据,并评估其偏倚风险。
在纳入的 16 项 RCT 中,有 11 项报告了低价值医学检测使用量的统计学显著减少。干预组和对照组之间相对减少差异的中位数为 17%(四分位距 12%至 24%)。使用提醒或审核/反馈的策略比没有这些组成部分的策略减少更多(22% 与 14%,22% 与 13%),针对患者的策略比非针对患者的策略减少更多(51% 与 17%)。很少有研究调查减少低价值检测使用的效果、不良事件、成本效益或与患者报告结果相关的可持续性。
本综述表明,有可能减少初级保健中低价值医学检测的使用,尤其是通过使用包括提醒、审核/反馈和针对患者的干预等多个组成部分。为了在初级保健环境中广泛实施这些策略,不仅需要研究其有效性,还需要研究不良事件、成本效益和患者报告结果。